Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Regeneron revenue
Regeneron's revenue is $14.2 billion.
What is Regeneron's revenue?
- Regeneron's revenue growth from 2000 to 2024 is 23,859.11%.
- Regeneron has 9,123 employees, and the revenue per employee ratio is $1,556,724.
- Regeneron's peak quarterly revenue was $5.1B in 2021(q2).
- Regeneron peak revenue was $16.1B in 2021.
- Regeneron annual revenue for 2023 was 13.1B, 7.76% growth from 2022.
- Regeneron annual revenue for 2024 was 14.2B, 8.27% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Regeneron historical revenue
Regeneron's peak revenue was $16.1B in 2021. The peak quarterly revenue was $5.1B in 2021(q2).
Regeneron's revenue increased from $59.3m in 2000 to $14.2B currently. That's a 23,859.11% change in annual revenue.
Regeneron annual revenue
Regeneron annual revenue over time
| Fiscal year / year | Regeneron revenue |
|---|---|
| 2009 | $379.3M |
| 2010 | $459.1M |
| 2011 | $445.8M |
| 2012 | $1.4B |
| 2013 | $2.1B |
| 2014 | $2.8B |
| 2015 | $4.1B |
| 2016 | $4.9B |
| 2017 | $5.9B |
| 2018 | $5.1B |
| 2019 | $6.6B |
| 2020 | $8.5B |
| 2021 | $16.1B |
| 2022 | $12.2B |
| 2023 | $13.1B |
| 2024 | $14.2B |
How accurately did Regeneron's revenue projections match actual performance?
Regeneron annual growth
Regeneron saw the greatest revenue growth in 2012, when revenue increased by 209.2%.
Regeneron had the lowest revenue growth in 2001, when revenue changed by -62.93%.
Regeneron annual growth rate over time
| Year | Regeneron growth |
|---|---|
| 2009 | 59%↑ |
| 2010 | 21%↑ |
| 2011 | -3%↓ |
| 2012 | 209%↑ |
| 2013 | 53%↑ |
| 2014 | 34%↑ |
| 2015 | 46%↑ |
| 2016 | 18%↑ |
| 2017 | 21%↑ |
| 2018 | -12%↓ |
| 2019 | 27%↑ |
| 2020 | 30%↑ |
| 2021 | 89%↑ |
| 2022 | -24%↓ |
| 2023 | 8%↑ |
| 2024 | 8%↑ |
Regeneron quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Regeneron quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $75.0M | $90.0M | $117.5M | $96.8M |
| 2010 | $103.5M | $115.9M | $106.0M | $133.7M |
| 2011 | $112.2M | $107.8M | $102.8M | $123.0M |
| 2012 | $231.8M | $304.4M | $427.7M | $414.6M |
| 2013 | $439.7M | $457.6M | $597.0M | $610.4M |
| 2014 | $625.7M | $665.7M | $725.8M | $802.3M |
| 2015 | $869.6M | $998.6M | $1.1B | $1.1B |
| 2016 | $1.2B | $1.2B | $1.2B | $1.2B |
| 2017 | $1.3B | $1.5B | $1.5B | $1.6B |
| 2018 | $1.5B | $1.6B | $1.7B | $362.6M |
| 2019 | $1.4B | $1.6B | $1.7B | $1.9B |
| 2020 | $1.8B | $2.0B | $2.3B | $2.4B |
| 2021 | $2.5B | $5.1B | $3.5B | $5.0B |
| 2022 | $3.0B | $2.9B | $2.9B | $3.4B |
| 2023 | $3.2B | $3.2B | $3.4B | $3.4B |
| 2024 | $3.1B | $3.5B | $3.7B | $3.8B |
Regeneron jobs nearby
Do you work at Regeneron?
Is Regeneron transparent about its revenue structure?
Regeneron financial information
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 9,123 |
| Date Founded | 1988 |
| Headquarters | Tarrytown, New York |
| Number of Locations | 8 |
| Revenue | $14.2B |
| Net Income | $4,338,400,000 |
| Gross Proft | $12.2B (2024) |
| PE Ratio | 8.95 |
| Tax Rate | 0.1% |
| Market Capitalization | $39.5B |
| Total Assets | $29,214,500,000 |
| Ticker | REGN |
Regeneron jobs you might like
Regeneron financing
Regeneron received early financing of $8.9M on 2016-08-22.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Equity | $8.9M | 08/2016 |
Regeneron investors
| Investors | Security type |
|---|---|
| U.S. Department of Health and Human Services (HHS) | Post Ipo Equity |
Regeneron competitors
Regeneron's top competitor, Johnson & Johnson, earned an annual revenue of $88.8B.
Regeneron's smallest competitor is T2 Biosystems with revenue of $7.2M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 583 |
| Johnson & Johnson | $76,686 | $88.8B | 134,500 | 1,440 |
| Sanofi Genzyme | $84,495 | $4.6B | 12,000 | - |
| Merck | $90,328 | $64.2B | 74,000 | 1,448 |
| Amgen | $93,349 | $33.4B | 22,000 | 561 |
| Baxter International | $54,368 | $10.6B | 48,000 | 160 |
| Vertex Pharmaceuticals | $95,952 | $11.0B | 3,400 | 186 |
| Zoetis | $87,092 | $9.3B | 11,300 | 214 |
| Pfizer | $70,868 | $63.6B | 78,500 | 331 |
| Genentech | $97,473 | $166.9M | 13,638 | 509 |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Regeneron highest paying jobs
Zippia gives an in-depth look into the details of Regeneron, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Regeneron. The employee data is based on information from people who have self-reported their past or current employments at Regeneron. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Regeneron. The data presented on this page does not represent the view of Regeneron and its employees or that of Zippia.
Regeneron may also be known as or be related to Regeneron, Regeneron Pharmaceuticals, Regeneron Pharmaceuticals Inc, Regeneron Pharmaceuticals Inc. and Regeneron Pharmaceuticals, Inc.